CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Ph...

FDA Drug Recall #D-0281-2023 — Class II — December 27, 2022

Recall Summary

Recall Number D-0281-2023
Classification Class II — Moderate risk
Date Initiated December 27, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sentara Infusion Services
Location Chesapeake, VA
Product Type Drugs
Quantity 3 bags

Product Description

CEFOXITIN (a) 1GM IN NS 50ML,(b) 2GM IN NS 100ML, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,

Reason for Recall

Lack of sterility assurance

Distribution Pattern

Dispensed to Patients Nationwide.

Lot / Code Information

Beyond Use date December 30, 2022

Other Recalls from Sentara Infusion Services

Recall # Classification Product Date
D-0296-2023 Class II HYDROMORPHONE (a) 1MG/ML IN NS, 50ML, 75 ML, 1... Dec 27, 2022
D-0323-2023 Class II VANCOMYCIN (a)700 MG NS 140ML, (b) 1000MG IN NS... Dec 27, 2022
D-0306-2023 Class II METRONIDAZOLE 500MG 100ML, antibiotic, Rx Only,... Dec 27, 2022
D-0297-2023 Class II IMIPENEM/CILASTATIN 2000MG IN NS 400ML, antibio... Dec 27, 2022
D-0321-2023 Class II TPN (a) 95GM/AA, 385/DEX, 50GM/LIP 1800ML, (b)T... Dec 27, 2022

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.